Kyowa Hakko Kirin | 4151 - Ebitda


Kyowa Hakko Kirin reported JPY53.91B in EBITDA for its fiscal quarter ending in June of 2026.





Ebitda Change Date
Astellas Pharma JPY 98.93B 84.75B Mar/2026
Chugai Pharma JPY 158.77B 10.24B Mar/2026
Daiichi Sankyo JPY 101.6B 22.81B Mar/2025
Eisai JPY 34.15B 34.48B Jun/2026
Kyowa Hakko Kirin JPY 53.91B 36.74B Jun/2026
M3 JPY 15.05B 15.35B Mar/2026
Otsuka Holdings JPY 156.66B 56.89B Mar/2026
Shionogi JPY 87.79B 59.04B Jun/2026
Sumitomo Dainippon JPY 1.43B 78.97B Mar/2026
Takeda JPY 364.46B 214.21B Jun/2026
Terumo JPY 57.88B 12.1B Mar/2026